Compositions and methods for inhibiting expression of Eg5 gene

Details for Australian Patent Application No. 2007233109 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Geick, Anke; Vornlocher, Hans-Peter; Bumcrot, David; Tan, Pamela

Agent FB Rice

Pub. Number AU-B-2007233109

PCT Pub. Number WO2007/115168

Priority 60/787,762 31.03.06 US; 60/870,259 15.12.06 US

Filing date 30 March 2007

Wipo publication date 11 October 2007

Acceptance publication date 14 October 2010

International Classifications

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/70 (2006.01) - Carbohydrates

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

23 October 2008 PCT application entered the National Phase

  PCT publication WO2007/115168 Priority application(s): WO2007/115168

14 October 2010 Application Accepted

  Published as AU-B-2007233109

10 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007233110-Polymeric materials as stomach filler and their preparation

2007233106-Styrene-maleic anhydride copolymers for bioapplications and their preparation